About
Bristol Myers Squibb (BMS) is a global biopharmaceutical company headquartered in Princeton, New Jersey. The company specializes in the discovery, development, manufacturing, and marketing of innovative prescription medicines and biologics. BMS focuses on serious diseases across various therapeutic areas, including oncology, hematology, immunology, cardiovascular disease, neuroscience, HIV/AIDS, diabetes, hepatitis, and rheumatoid arthritis. BMS operates research and development sites in the US, Europe, and Asia, with manufacturing facilities in several countries. The company reported total revenues of approximately $46.2 billion for fiscal 2022. Its product portfolio includes notable medicines such as Opdivo, Reblozyl, Krazati, Sprycel, and Sotyktu. BMS is committed to advancing health equity and emphasizes responsible business practices and a collaborative culture centered on scientific innovation and patient impact.
Technologies
Keywords
Company Information
-
Employees 31
-
Founded 2012
Location
Jeddah, Makkah Province, Saudi Arabia